Clinical Trial Update: Umbrella Trial of Subtype-Targeted Therapies in ER+/HER2- Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 umbrella trial testing subtype-targeted therapies for estrogen receptor-positive, HER2-negative breast cancer has completed, and results have been pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Estrogen Receptor-positive Breast Cancer

Snippet

Sponsor: Jennifer Lee Caswell-Jin | Conditions: Breast Cancer, HER2-negative Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2026-01-22